Latest Insider Transactions at Cigna Corp (CI)
This section provides a real-time view of insider transactions for Cigna Corp (CI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cigna Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cigna Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2022
|
Paul A Sanford EVP Operations |
SELL
Open market or private sale
|
Direct |
374
-3.94%
|
$106,590
$285.0 P/Share
|
|
Aug 09
2022
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Open market or private sale
|
Direct |
7,044
-45.33%
|
$2,014,584
$286.89 P/Share
|
|
Aug 09
2022
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,044
+31.19%
|
$408,552
$58.73 P/Share
|
|
Aug 01
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Open market or private sale
|
Direct |
902
-11.77%
|
$246,246
$273.98 P/Share
|
|
Jul 11
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,897
+7.5%
|
$431,653
$149.13 P/Share
|
|
Jul 08
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
9,505
-22.44%
|
$2,661,400
$280.0 P/Share
|
|
Jul 08
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
9,505
+18.33%
|
$1,416,245
$149.13 P/Share
|
|
Jul 08
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
860
+2.06%
|
$103,200
$120.89 P/Share
|
|
Jul 08
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Exercise of conversion of derivative security
|
Direct |
466
+5.73%
|
$89,472
$192.02 P/Share
|
|
Jul 07
2022
|
Eric P Palmer Officer |
SELL
Open market or private sale
|
Direct |
6,521
-14.02%
|
$1,793,275
$275.0 P/Share
|
|
Jul 07
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,557
+10.68%
|
$666,840
$120.89 P/Share
|
|
Jul 07
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Open market or private sale
|
Direct |
5,094
-41.43%
|
$1,400,850
$275.0 P/Share
|
|
Jul 07
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,094
+29.3%
|
$978,048
$192.02 P/Share
|
|
Jul 07
2022
|
Paul A Sanford EVP Operations |
SELL
Open market or private sale
|
Direct |
374
-3.79%
|
$102,850
$275.0 P/Share
|
|
Jun 29
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,104
+3.25%
|
$153,456
$139.22 P/Share
|
|
Jun 28
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
3,458
-9.82%
|
$933,660
$270.0 P/Share
|
|
Jun 28
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,458
+8.94%
|
$480,662
$139.22 P/Share
|
|
May 18
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,869
+4.47%
|
$944,280
$120.89 P/Share
|
|
May 17
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,261
-11.28%
|
$12,220,470
$270.79 P/Share
|
|
May 17
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,261
+18.03%
|
$5,431,320
$120.89 P/Share
|
|
Apr 27
2022
|
William J De Laney Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+3.32%
|
-
|
|
Apr 27
2022
|
Eric J Foss Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+2.18%
|
-
|
|
Apr 27
2022
|
Neesha Hathi Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+34.66%
|
-
|
|
Apr 27
2022
|
Kathleen M Mazzarella Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+15.37%
|
-
|
|
Apr 27
2022
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+15.37%
|
-
|
|
Apr 27
2022
|
George Kurian Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+29.19%
|
-
|
|
Apr 27
2022
|
Kimberly A. Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+22.75%
|
-
|
|
Apr 27
2022
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+13.9%
|
-
|
|
Apr 27
2022
|
Donna F Zarcone Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+2.67%
|
-
|
|
Apr 27
2022
|
Eric C Wiseman Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+3.45%
|
-
|
|
Apr 26
2022
|
John Partridge Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+0.66%
|
-
|
|
Apr 21
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
863
+2.28%
|
$119,957
$139.22 P/Share
|
|
Apr 21
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,749
+4.61%
|
$929,880
$120.89 P/Share
|
|
Apr 20
2022
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
5,918
-14.1%
|
$1,568,270
$265.0 P/Share
|
|
Apr 20
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,918
+12.36%
|
$822,602
$139.22 P/Share
|
|
Apr 20
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,380
-4.97%
|
$12,116,460
$267.45 P/Share
|
|
Apr 20
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,004
+21.11%
|
$6,360,480
$120.89 P/Share
|
|
Apr 19
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
41,788
-7.91%
|
$10,906,668
$261.35 P/Share
|
|
Apr 19
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,788
+18.27%
|
$5,014,560
$120.89 P/Share
|
|
Apr 19
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
844
+2.29%
|
$117,316
$139.22 P/Share
|
|
Apr 18
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
3,717
-1.26%
|
$966,420
$260.89 P/Share
|
|
Apr 18
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,717
+2.44%
|
$446,040
$120.89 P/Share
|
|
Apr 18
2022
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
12,070
-13.7%
|
$3,126,130
$259.05 P/Share
|
|
Apr 18
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,936
+11.16%
|
$825,104
$139.22 P/Share
|
|
Apr 07
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,311
+3.1%
|
$102,258
$78.03 P/Share
|
|
Apr 06
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Open market or private sale
|
Direct |
999
-12.18%
|
$249,750
$250.0 P/Share
|
|
Apr 06
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
5,000
-13.61%
|
$1,250,000
$250.0 P/Share
|
|
Apr 06
2022
|
Eric P Palmer Officer |
SELL
Open market or private sale
|
Direct |
8,126
-17.02%
|
$2,031,500
$250.0 P/Share
|
|
Apr 06
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,656
+12.23%
|
$519,168
$78.03 P/Share
|
|
Mar 03
2022
|
Eric P Palmer Officer |
BUY
Bona fide gift
|
Indirect |
400
+35.24%
|
-
|